Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May;68(5):1797-1814.
doi: 10.1007/s10620-022-07812-1. Epub 2023 Jan 4.

Cystic Fibrosis-Related Gut Dysbiosis: A Systematic Review

L R Caley  1 , H White  2 , M C de Goffau  3   4 , R A Floto  5   6 , J Parkhill  7 , B Marsland  8 , D G Peckham  9   10
Affiliations
Free article

Cystic Fibrosis-Related Gut Dysbiosis: A Systematic Review

L R Caley et al. Dig Dis Sci. 2023 May.
Free article

Abstract

Background and aims: Cystic Fibrosis (CF) is associated with gut dysbiosis, local and systemic inflammation, and impaired immune function. Gut microbiota dysbiosis results from changes in the complex gut milieu in response to CF transmembrane conductance regulator (CFTR) dysfunction, pancreatic malabsorption, diet, medications, and environmental influences. In several diseases, alteration of the gut microbiota influences local and systemic inflammation and disease outcomes. We conducted a systematic review of the gut microbiota in CF and explored factors influencing dysbiosis.

Methods: An electronic search of three databases was conducted in January 2019, and re-run in June 2021. Human, animal, and in vitro studies were included. The primary outcome was differences in the gut microbiota between people with CF (pwCF) and healthy controls. Secondary outcomes included the relationship between the gut microbiota and other factors, including diet, medication, inflammation, and pulmonary function in pwCF.

Results: Thirty-eight studies were identified. The literature confirmed the presence of CF-related gut dysbiosis, characterized by reduced diversity and several taxonomic changes. There was a relative increase of bacteria associated with a pro-inflammatory response coupled with a reduction of those considered anti-inflammatory. However, studies linking gut dysbiosis to systemic and lung inflammation were limited. Causes of gut dysbiosis were multifactorial, and findings were variable. Data on the impact of CFTR modulators on the gut microbiota were limited.

Conclusions: CF-related gut dysbiosis is evident in pwCF. Whether this influences local and systemic disease and is amenable to interventions with diet and drugs, such as CFTR modulators, requires further investigation.

Keywords: CFTR; Cystic fibrosis; Diet; Dysbiosis; Gut microbiota; Inflammation.

PubMed Disclaimer

References

    1. Al Bataineh MT, Dash NR, Bel Lassen P et al. Revealing links between gut microbiome and its fungal community in Type 2 Diabetes Mellitus among Emirati subjects: a pilot study. Sci Rep 2020;10:9624. https://doi.org/10.1038/s41598-020-66598-2 . - DOI - PubMed - PMC
    1. Anand S, Mande SS. Diet, microbiota and gut-lung connection. Front Microbiol 2018;9:2147. https://doi.org/10.3389/fmicb.2018.02147 . - DOI - PubMed - PMC
    1. Anderson JL, Miles C, Tierney AC. Effect of probiotics on respiratory, gastrointestinal and nutritional outcomes in patients with cystic fibrosis: a systematic review. J Cyst Fibros 2017;16:186–197. https://doi.org/10.1016/j.jcf.2016.09.004 . - DOI - PubMed
    1. Antosca KM, Chernikova DA, Price CE et al. Altered stool microbiota of infants with cystic fibrosis shows a reduction in genera associated with immune programming from birth. J Bacteriol. 2019. https://doi.org/10.1128/jb.00274-19 . - DOI - PubMed - PMC
    1. Arboleya S, Watkins C, Stanton C, Ross RP. Gut bifidobacteria populations in human health and aging. Front Microbiol 2016;7:1204. https://doi.org/10.3389/fmicb.2016.01204 . - DOI - PubMed - PMC

Publication types

Substances